The EE mechanisms responsible for alleviating dyslipidemia and AI may relate to the increased lipoprotein lipase activity that mediates triglyceride hydrolysis and hepatic cholesterol excretion [37]. This evidence concerns the gene LPL and metabolic syndrome.